FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Blood/body fluid withdrawal Procedure
Blood/body fluid withdrawal NOS Procedure
Blood/body fluid withdrawal NOS Procedure
Blount's disease (disorder) Blount disease
Blount's disease (disorder) Blount disease
Blue green algae Phylum Cyanobacteria
Bluetongue virus subgroup (organism) Bluetongue virus (organism)
Body fluid analysis or microscopy (procedure) Body fluid analysis
Body system (body structure) structure d'un système corporel
Bone TNM finding (finding) American Joint Committee on Cancer allowable value
Bone dysplasia Azouz type (disorder) Disorganised development of cartilaginous and fibrous components of the skeleton
Bone grafting Grafting - action
Booster diphtheria and tetanus double vaccination Administration of booster dose of diphtheria and tetanus vaccine
Booster diphtheria and tetanus double vaccination Administration of booster dose of diphtheria and tetanus vaccine
Borderline angle-closure glaucoma of bilateral eyes (disorder) Angle closure glaucoma suspect of bilateral eyes
Borderline angle-closure glaucoma of left eye Angle closure glaucoma suspect of left eye
Borderline angle-closure glaucoma of right eye (disorder) Angle closure glaucoma suspect of right eye
Borderline glaucoma Glaucoma suspect
Borderline glaucoma (disorder) Glaucoma suspect
Borderline glaucoma steroid responder Glaucoma suspect caused by corticosteroid
Bordetella pertussis rough phase IV (organism) Pseudomonas pertucinogena
Boric acid 1% eye drops (product) Product containing precisely boric acid 10 milligram/1 milliliter conventional release eye solution (clinical drug)
Boric acid topical agent (substance) Boric acid
Born in Cape Verde Islands Born in Cabo Verde (finding)
Born in Cape Verde Islands Born in Cabo Verde (finding)
Born in Cape Verde Islands Born in Cabo Verde (finding)
Bos bison (organism) Bison bison (organism)
Bos gaurus Bos frontalis
Bos taurus X Bos bison hybrid cattle breed (organism) Bison bison X Bos taurus hybrid (organism)
Both patent perméable
Both uteri utérus (structure corporelle)
Bovine thrombin 20000iu powder for conventional release cutaneous solution Bovine thrombin only product in cutaneous dose form
Bovine thrombin 20000iu powder for topical solution + 20mL vial diluent (product) Bovine thrombin only product in cutaneous dose form
Bovine thrombin 5000iu powder for conventional release cutaneous solution (product) Bovine thrombin only product in cutaneous dose form
Bovine thrombin 5000iu powder for topical solution + 5mL vial diluent (product) Bovine thrombin only product in cutaneous dose form
Bowed tibia, radial anomaly, osteopenia, fracture syndrome (disorder) Dysplasia with decreased bone density
Brachialgia brachialgie
Brachymetapodia of first metatarsal Brachymetatarsia of first metatarsal
Brachymetapodia of fourth metatarsal Brachymetatarsia of fourth metatarsal
Brachyolmia - Hobaek type (disorder) Autosomal recessive brachyolmia (disorder)
Brachyolmia type 1 Toledo type (disorder) Autosomal recessive brachyolmia (disorder)
Brachyrachia (short spine dysplasia) Brachyolmia
Brain excision Excision of brain
Brain injury with open intracranial wound and unspecified state of consciousness (disorder) Brain injury with open intracranial wound
Brain injury without open intracranial wound and with unspecified state of consciousness (disorder) Brain injury without open intracranial wound
Brain stem contusion with open intracranial wound and unspecified state of consciousness (disorder) Brain stem contusion with open intracranial wound
Brain stem contusion without open intracranial wound and with unspecified state of consciousness Brain stem contusion without open intracranial wound (disorder)
Brain stem laceration with open intracranial wound and unspecified state of consciousness Brain stem laceration with open intracranial wound
Brain stem laceration without open intracranial wound and with unspecified state of consciousness Brain stem laceration without open intracranial wound
Branching bacille Gram positif Branching Gram-positive bacilli present (finding)
Breast TNM finding (finding) American Joint Committee on Cancer allowable value
Breast reconstruction, bilateral, with bilateral free transverse rectus abdominus muscle flaps (procedure) Reconstruction of bilateral breasts using free transverse rectus abdominis myocutaneous flap (procedure)
Breast screening declined Breast cancer screening declined (situation)
Breast screening declined (finding) Breast cancer screening declined (situation)
Breast screening declined Breast cancer screening declined (situation)
Breath holding attacks (finding) Breath holding spell (finding)
Breathing exercise (regime/therapy) Physiotherapeutic breathing exercise (regime/therapy)
Breathing problem Abnormal breathing (finding)
Bretylium tosylate 50mg/mL injection solution prefilled syringe (product) Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Brevibacterium acetylicum Exiguobacterium acetylicum
Brevibacterium incertum Desemzia incerta (organism)
Brevibacterium mecbrellneri Brevibacterium mcbrellneri (organism)
Brevibacterium oxydans Microbacterium oxydans
Brief atonic seizure (finding) Atonic seizure
Brimonidine 0.2%/timolol 0.5% eye drops (product) Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)
British Association for Adoption and Fostering B1/2 - adoption: birth history (record artifact) Adoption - birth history report (record artifact)
Broad bean - dietary Broad bean (substance)
Broccoli - dietary Broccoli (substance)
Brocq's neurodermatitis (disorder) dermatite atopique
Brocq's neurodermatitis dermatite atopique
Bromelin specific extract (product) Product containing bromelains (medicinal product)
Bromhexine hydrochloride adverse reaction Adverse reaction to bromhexine
Bromine complexes adverse reaction Adverse reaction caused by bromine and/or bromine compound (disorder)
Bromocriptine [endocrine use] (product) Product containing bromocriptine (medicinal product)
Bromocriptine [endocrine] (product) Product containing bromocriptine (medicinal product)
Bromocriptine [parkinsons] (product) Product containing bromocriptine (medicinal product)
Bromodiphenhydramine+codeine 12.5mg/5mL/10 mg/5mL syrup (product) Product containing precisely bromazine hydrochloride 2.5 milligram/1 milliliter and codeine phosphate 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup (product) Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet (product) Brompheniramine and pseudoephedrine only product in oral dose form
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet (product) Brompheniramine and pseudoephedrine only product in oral dose form
Brompheniramine maleate 10mg/mL injection solution ampule (product) Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup (product) Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution
Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup (product) Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup (product) Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup (product) Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 60mg/5mL syrup (product) Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 30mg/5mL 60mg/5mL syrup (product) Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution
Bromsulfalein bromesulfonephtaléine
Bromsulphalein clearance Sulfobromophthalein clearance study (procedure)
Bronchioloalveolar adenocarcinoma of lung (disorder) Adenocarcinoma of lung
Bronchioloalveolar carcinoma (disorder) Adenocarcinoma of lung
Bronchoscopy with unlisted bronchoscopic procedure (procedure) Bronchoscopy
Brucella rangiferi tarandi Brucella suis biovar 4
Brucellosis due to other Brucella sp. (disorder) Brucellosis
Brussels sprouts - dietary Brussels sprouts (substance)
Bryophyllum Genus Kalanchoe (organism)
Bryozoan (organism) Phylum Bryozoa (organism)
Budesonide 0.5mg/2mL suspension (product) Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug)
Budesonide 160mcg/formoterol 4.5mcg dry powder inhaler (product) Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation
Budesonide 180micrograms dry powder for inhalation (product) Product containing only budesonide in pulmonary dose form (medicinal product form)
Budesonide 1mg/2mL nebulization unit (product) Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug)

Start Previous Page 13 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start